Results 341 to 350 of about 281,573 (395)

Impact of the addition of antithymocyte globulin to post‐transplantation cyclophosphamide in haploidentical transplantation with peripheral blood compared to post‐transplantation cyclophosphamide alone: A retrospective study on behalf of the Cellular Therapy and Immunobiology Working Party of the European Society for Blood and Marrow Transplantation

British Journal of Haematology, EarlyView.
Summary In the setting of haploidentical haematopoietic cell transplantation (HCT), post‐transplant cyclophosphamide (PTCy) has dramatically reduced the incidence of graft‐versus‐host disease (GVHD) and non‐relapse mortality. To further reduce GVHD incidence, the addition of antithymocyte globulin (ATG) to PTCy was evaluated in retrospective and non ...
Antoine Capes, Jarl E. Mooyaart, Didier Blaise, Stefania Bramanti, Mi Kwon, Mohamad Mohty, Patrice Chevallier, Jan Vydra, Péter Reményi, Edouard Forcade, Lucía López Corral, Maija Itälä‐Remes, Ali Bazarbachi, Enrico Derenzini, Jorinde D. Hoogenboom, Jürgen Kuball, Giorgia Battipaglia, Florent Malard, Annalisa Ruggeri   +18 more
wiley   +1 more source

Fatty acid metabolism shapes immune responses in chronic lymphocytic leukemia. [PDF]

Biomark Res
Zhang Y, Ma J, Li P, Lu K, Han Y, Hu X, Fang X, Wang X, Zhang Y.   +8 more
europepmc   +1 more source

IGHV1 usage is associated with lymphadenopathy and aggressive disease in the TCL1 mouse model for chronic lymphocytic leukemia

Drothler S, Scherhäufl C, Suete C, Parigger T, Gassner FJ, Pleyer L, Egle A, Greil R, Geisberger R, Zaborsky N.   +9 more
europepmc   +1 more source

Correction: Venetoclax treatment for chronic lymphocytic leukemia/small lymphocytic leukemia in Japan: post-marketing surveillance. [PDF]

Int J Hematol
Ito T, Kamimura T, Kiguchi T, Kato K, Takenaka R, Kobayashi M, Ito A, Sakai M, Izutsu K.   +8 more
europepmc   +1 more source

Chronic lymphocytic leukemia.

Experimental oncology, 2013
openaire   +2 more sources

Clonal relatedness as a prognostic marker in Richter transformation of chronic lymphocytic leukemia: a systematic review. [PDF]

Blood Adv
Barrett A, Harris C, Eyre TA.
europepmc   +1 more source

High-intensity interval training and strength conditioning in patients with chronic lymphocytic leukemia: a systematic review. [PDF]

Syst Rev
Cunha PMP, Ribeiro RJ, Pizarro A, Mota J, Ribeiro JCD.   +4 more
europepmc   +1 more source

Resistance to targeted therapies in chronic lymphocytic leukemia: Current status and perspectives for clinical and diagnostic practice. [PDF]

Leukemia
Blombery P, Chatzikonstantinou T, Gerousi M, Rosenquist R, Gaidano G, Pospisilova S, Roberts AW, Birkinshaw RW, Rossi D, Scarfo L, Seymour JF, Stilgenbauer S, Wiestner A, Woyach JA, Brown JR, Ghia P, Stamatopoulos K, ERIC, the European Research Initiative on CLL.   +18 more
europepmc   +1 more source

Incremental immunogenicity of multiple doses of SARS‐CoV‐2 vaccination in patients with haematological malignancies

British Journal of Haematology, EarlyView.
Abi Vijenthira, Sita Bhella, Katrina Hueniken, Allison M. Wilkin, Michael Sebag, Peng Wang, Lisa K. Hicks, Annette E. Hay, Sarit Assouline, Amaris Balitsky, Graeme Fraser, Joy Mangel, Carolyn Owen, Anthony Reiman, Laurie Sehn, Heather Sutherland, Corey Arnold, Tamara Leite, Erinn McCarthy, Angela Crawley, Curtis Cooper, Marc‐Andre Langlois, C. Arianne Buchan, VIP Study Investigators   +23 more
wiley   +1 more source

The Effect of T-Lymphocyte Subgroups at Diagnosis on the Prognosis of Chronic Lymphocytic Leukemia.

Acta Haematol
Seyithanoglu D, Sert EN, Ozbalak M, Mastanzade M, Erdem S, Yenerel MN.   +5 more
europepmc   +1 more source